This page contains brief information about vincristine sulfate liposome and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
FDA label information for this drug is available at DailyMed.
Use in Cancer
Vincristine sulfate liposome is approved to treat:
- Acute lymphoblastic leukemia that is Philadelphia chromosome negative. It is used in patients whose disease has relapsed two or more times or has not gotten better with two or more types of treatment.
Vincristine sulfate liposome is also being studied in the treatment of other types of cancer.
Vincristine sulfate liposome is a form of vincristine sulfate contained inside liposomes (very tiny particles of fat). This form may work better than other forms of vincristine sulfate and have fewer side effects. Also, because its effects last longer in the body, it doesn’t need to be given as often. For more information about vincristine sulfate that may apply to vincristine sulfate liposome, see the Drug Information Summary for Vincristine Sulfate.
More About Vincristine Sulfate Liposome
Definition from the TCH Drug Dictionary – Detailed scientific definition and other names for this drug.
MedlinePlus Information on Vincristine Sulfate Liposome – A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.
